Search for: "Mylan Pharmaceuticals v. FDA" Results 141 - 160 of 233
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Nov 2010, 1:21 am by Kelly
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to… [read post]
27 Oct 2010, 3:38 am by Kelly
Abbott (EPLAW) Lunesta (Eszopiclone) – US: Cobalt Pharmaceuticals and Sepracor settle Lunesta patent litigation (Patent Docs) Mirapex (Pramipexole) – US: Mylan receives approval for generic version of Mirapex tablets (SmartBrief) Oracea (Doxycyline) – US: Mylan seeks declaratory judgment of non-infringement and invalidity based on ANDA filing: Mylan v Galderma (Patent Docs) Perlane, Restylane (Hyaluronic acid) – US: Genzyme files… [read post]
19 Oct 2010, 10:42 pm by Marie Louise
  Highlights this week included: CAFC denies outsourcing of inventorship to foreign countries: Solvay v. [read post]
12 Oct 2010, 8:56 pm by Kelly
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
6 Oct 2010, 4:22 am by Kelly
General Update on the Indo-E.U. trade dispute before the WTO (Spicy IP) Australia: Proceedings in other jurisdictions no excuse for delay: Wyeth v The Kennedy Institute of Rheumatology (Patentology) EU: Positive opinions on Paediatric Investigation Plans (The SPC Blog) EU: Guidelines for biosimilar antibodies in Europe due in November (Patent Docs) Netherlands: Court of Appeal of The Hague dismisses request to suspend execution of judgment in first instance: Sandoz v Leo… [read post]
28 Sep 2010, 3:14 pm by Kelly
Par Pharmaceutical, Inc; Schering-Plough Healthcare Products, Inc. et al. v. [read post]
15 Sep 2010, 2:40 am by Kelly
KG v Apotex Pty Ltd (No 2) (Patentology) MoviPrep – US: Salix and Norgine settle with Novel in patent dispute over MoviPrep (Patent Docs) Nexavar (Sorafenib) – India: Nexavar patent infringement suit before Delhi HC goes directly to trial: Bayer v Cipla (Spicy IP) Simcor (Niacin/Simvastatin) – US: Abbott files patent infringement suit against Teva following Para IV challenge (Patent Docs) Vancocin (Vancomycin) – US: ViroPharma sues FDA over generic… [read post]
7 Sep 2010, 6:10 pm by Kelly
biuras, Amgen Europe BV (The SPC Blog) Aricept (Donepezil) – US: District Court denies Apotex declaratory judgment motion on generic Aricept; does not accept ‘prompt launch’ and ‘indefinite delay’ jurisdiction theories (FDA Law Blog) Chantix (Varenicline) – US: Pfizer files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (AboutLawsuits.com) Copaxone (Glatiramer) – US: Court denies Sandoz/Momenta’s… [read post]
31 Aug 2010, 10:01 pm by Kelly
: Sanofi-Aventis v FDA, Sandoz (FDA Law Blog) (GenericsWeb)   Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
25 Aug 2010, 12:37 am by Kelly
Osmotica Pharmaceutical Corp (Patent Docs) Seroquel (Quetiapine) – US: Patent infringement suit filed following Para IV certification: Astrazeneca Pharmaceuticals LP et al. v. [read post]
28 Jul 2010, 12:06 am by Kelly
Sanofi sues FDA over generic LOVENOX approval (FDA Law Blog) (FDA Law Blog) Lupron (Leuprolide) – US: False marking complaint filed concerning Lupron products: Promote Innovation LLC v. [read post]
8 Jul 2010, 1:25 pm by FDABlog HPM
Court of Appeals for the Federal Circuit issued its April 2010 decision in Novo Nordisk A/S v. [read post]